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ABSTRACT 
 
There is an increasing incidence of coronary artery disease in India. We therefore need a tool to evaluate 
the severity and prognosis of this acute myocardial infarction. In acute myocardial infarction, the function 
of plaque rupture and inflammation has already been identified. Aim: To study the organization of LDL-
C/HDL-C ratio and inflammatory marker CRP in acute myocardial infarction. Methods and Material: Patients 
who have been diagnosed as acute myocardial infarction (ST Elevation Acute myocardial Infarction or 
Unstable angina/Non ST Elevation Myocardial Infarction) and admitted to ICCU of Rajiv Gandhi institute of 
Medical Sciences, Kadapa, AP. are the subjects. Sample consists of 100 cases of acute myocardial infarction. 
Case history was taken from the patients, and studied according to proforma. Conclusion: Elevated levels of 
CRP are independent indicators of adverse effects. When contrast with the LDL / HDL ratio, CRP is used for 
risk stratification and as a prognostic predictor. These findings suggest that in patients with acute 
myocardial infarction, raised CRP Levels is significant as compared to LDL/HDL ratio. 
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INTRODUCTION 
The 20th century saw significant changes in 
cardiovascular disease trends. Cardiovascular 
disease accounts for about 12 million deaths per year 
and is the world's most common cause of death(1). 
Asian Indians have a much higher incidence of 
coronary artery disease than all other ethnic groups, 
whether living in their own country or elsewhere. In 
the developed world, cardiovascular system 
involvement throughout syphilitic and tuberculosis 
has become rare and rheumatic disease incidence has 
declined significantly. On the other hand, myocardial 
and tissue-related diseases were diagnosed with 
increasing frequency and the significance of arterial 
hypertension was well known(2). 
Consequently, myocardial infarction remains an 
important health issue and needs ongoing attention 
from basic and medical clinicians, epidemiologists, 
and practitioners. 
The advancement in atherosclerotic vascular disease 
pathophysiology has brought new insight into 
possible markers of secret atherosclerosis 
underlying and cardiovascular danger. Now, a 
number of novel inflammatory markers, particularly 
C-reactive protein (CRP), have been focused for a few 
days. The fact that inflammation is an important 
factor in acute myocardial infarction is becoming 
increasingly clear. Inflammatory cytokines from the 
inflamed tissue will be released with inflammation, 
which induces the liver to synthesize a variety of 
acute phase proteins, including the prototypic acute 
phase reactant, C reactive protein(3). 
For possible novel markers for cardiovascular risk 
assessment, prospective clinical studies have tested 
multiple acute phase proteins, cytokines and inter-
cellular adhesion molecules in accordance with 
laboratory evidence. For this function, CRP has 
several features that make this inflammatory marker 
particularly attractive. In response to acute injury, 
infection, or other inflammatory stimuli, CRP is well 
defined as a marker of systemic inflammation and is 
known to increase several hundred folds. The 
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concentrations remain stable in the absence of new 
stimuli over long periods of time and depend entirely 
on the level of hepatic development, rather than on 
factors that influence protein clearance(4). 
C reactive protein is a liver-produced plasma protein. 
This is a protein family member of pentraxin. CRP 
was originally discovered by Tillett and Francis(5) in 
1930 as a compound that interacted with C 
polysaccharide of pneumococcus in the serum of 
patients with acute inflammation. 
The two main plasma lipids are cholesterol and 
triglycerides that are insoluble in the plasma's 
aqueous setting and are solubilized by integrating 
them into lipoproteins. Lipoprotein consists of the 
central core of hydrophobic lipids (TG and 
cholesterol esters) and the outer monolayer which 
includes proteins called apoprotein or apolipoprotein 
which give their names to the complex. 
Lipoproteins are lipid and protein complexes that are 
necessary for cholesterol, triglycerides and fat-
soluble vitamins to be transported. The lipid 
reduction therapy presentation significantly reduces 
ASCVD's medical complications(6). 
Diabetes raises the LP(a) excess CAD risk by more 
than 3 times. LP(a) excess is also associated with 
rapid development of atherothrombosis in 
hypertensive patients and four fold higher risk of 
myocardial infarction. It should be noted that in those 
who had all 5 standard risk factors considered in the 
Framingham heart study, the risk of CAD was 
increased 20 fold(7). 
MATERIAL AND METHODS 
Patients who have been diagnosed as acute 
myocardial infarction (ST Elevation Acute myocardial 
Infarction or Unstable angina/Non ST Elevation 
Myocardial Infarction) and admitted to ICCU of Rajiv 
Gandhi institute of Medical Sciences, Kadapa, AP. are 
the subjects. Sample consists of 100 cases of acute 
myocardial infarction. Case history was taken from 
the patients, and studied according to proforma. 
Inclusion Criteria: 
100 patients admitted to ICCU of Rajiv Gandhi 
institute of Medical Sciences with the diagnosis of 
1. ST Elevation Acute myocardial Infarction (STEMI) 
2. Unstable angina/Non ST Elevation Myocardial 
Infarction (NSTEMI) 
Diagnosis of Acute myocardial infarction was made 
by history, physical examination and 
electrocardiogram. 
Exclusion Criteria: 
1. Patients below 45years of age. 
2. Individuals of rheumatic disease, chronic liver 
disease, renal disorders, diabetes, sepsis, and 
critically ill patients with infectious diseases of 
less than a month length and 3-month surgical 
procedure. 
3. Patient on statin therapy. 
In all patients, electrocardiography and 
echocardiography were done in addition to 
routine blood investigations. All patients were 
monitored and observed for complications 
development. 
RESULTS 
Between 59 and 69 years of age, the maximum 
incidence of acute coronary syndrome was observed, 
representing 35 (35 percent) patients. Youngest, 42, 
suffered from STEMI. Eighty-one years oldest was a 
male with UA / NSTEMI. 
A rate equal to or greater than 0.5 mg / dL is detected 
as positive, according to the qualitative method of 
measuring the measurement of C reactive proteins. 
Negative is a point below 0.5 mg / dL. 76(76 percent) 
of patients in our sample had detectable levels of C 
reactive protein (i.e. equal to or greater than 0.5 mg / 
dL). The table below shows high levels of C reactive 
protein and its relationship to complications. 





C < 3 
LDL-C/HDL-
C > 3 
Total 
< 0.5 mg/Dl 18 6 24 
> 0.5 mg/dL 60 16 76 
Total 78 22 100 
Price Chi Square found by correction Yates, X2yc= 
0.002. The value of p at one degree of freedom is very 
significant (p>0.01). It means that patients with high 
serum C reactive level also had LDL / HDL > 3 as 
opposed to patients with low serum C reactive level. 
DISCUSSION 
In our sample mean age of incidence of ACS is 59 
years. The mean age was seventh decade in the study 
of Foussas et al(8). and Mohmoud Suleiman et al.(9) 
And coronary artery diseases occur a decade earlier 
in the Indian subcontinent than in the western 
population. So, our patients ' average age is 
equivalent to the above reports. 
Fifty (50%) patients had lipid abnormalities in our 
study. High triglycerides and low HDL levels were the 
most prominent lipid abnormalities. 65.6 percent of 
patients had lipid abnormalities in Foussas et al(8). 
study. And 43 percent of patients had dyslipidemias 
in Mohmoud Suleiman et al(9). study. LDL / HDL ratio 
was taken in all patients. The LDL/HDL ratio of 100 
patients exceeded 3 in 18 patients and less than 4 in 
82 patients. Thus the ratio with the incidence of 
myocardial infarction is not significant (p<0.01). 
A rate equal to or greater than 0.5 mg / dL is detected 
as positive, according to the qualitative method of 
measuring the measurement of C reactive proteins. 
Negative is a point below 0.5 mg / dL. 76(76 percent) 
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of patients in our sample had detectable levels of C 
reactive protein (i.e. equal to or greater than 0.5 mg / 
dL). The table below shows high levels of C reactive 
protein and its relationship to complications. 
P Mishra et al(10) studied 50 cases of acute myocardial 
infarction and found that serum CRP admission 
concentration is an important prognostic indicator of 
their hospital stay. According to these findings, more 
adverse events were also associated with increased 
levels of plasma C Reactive Protein in our research. 
(JPMA 56:318;2006)High serum CRP levels rather 
than high LDL:HDL are associated with myocardial 
infarction in patients with myocardial infarction in 
NICVD. This study found that high serum C-reactive 
protein is significantly associated with myocardial 
infarction rather than high LDL:HDL, particularly in 
the 46-60 year age group. Low serum levels of high 
density lipoproteins were also associated with acute 
myocardial infarction (11). 
CONCLUSION: 
In the setting of acute myocardial infarction, plasma 
CRP levels on admission are used to identify high risk 
patients. The successful risk stratification given may 
be of particular value in the heterogeneous 
population of patients with acute myocardial 
infarction for early clinical decision-making and 
patient care. In fewer patients, the significant LDL / 
HDL ratio was increased. In contrast to the LDL / HDL 
ratio, the raised C reactive protein level is therefore 
more significant with the acute myocardial 
infarction.Elevated levels of CRP are independent 
indicators of adverse effects.When contrast with the 
LDL / HDL ratio, CRP is used for risk stratification and 
as a prognostic predictor.These findings suggest that 
in patients with acute myocardial infarction, raised 
CRP Levels is significant as compared to LDL/HDL 
ratio. 
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